Literature DB >> 25178411

Loss of PIKfyve in platelets causes a lysosomal disease leading to inflammation and thrombosis in mice.

Sang H Min1, Aae Suzuki1, Timothy J Stalker1, Liang Zhao1, Yuhuan Wang2, Chris McKennan3, Matthew J Riese1, Jessica F Guzman1, Suhong Zhang4, Lurong Lian1, Rohan Joshi1, Ronghua Meng5, Steven H Seeholzer3, John K Choi6, Gary Koretzky1, Michael S Marks5, Charles S Abrams1.   

Abstract

PIKfyve is essential for the synthesis of phosphatidylinositol-3,5-bisphosphate [PtdIns(3,5)P2] and for the regulation of endolysosomal membrane dynamics in mammals. PtdIns(3,5)P2 deficiency causes neurodegeneration in mice and humans, but the role of PtdIns(3,5)P2 in non-neural tissues is poorly understood. Here we show that platelet-specific ablation of PIKfyve in mice leads to accelerated arterial thrombosis, and, unexpectedly, also to inappropriate inflammatory responses characterized by macrophage accumulation in multiple tissues. These multiorgan defects are attenuated by platelet depletion in vivo, confirming that they reflect a platelet-specific process. PIKfyve ablation in platelets induces defective maturation and excessive storage of lysosomal enzymes that are released upon platelet activation. Impairing lysosome secretion from PIKfyve-null platelets in vivo markedly attenuates the multiorgan defects, suggesting that platelet lysosome secretion contributes to pathogenesis. Our findings identify PIKfyve as an essential regulator for platelet lysosome homeostasis, and demonstrate the contributions of platelet lysosomes to inflammation, arterial thrombosis and macrophage biology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25178411      PMCID: PMC4369914          DOI: 10.1038/ncomms5691

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  56 in total

Review 1.  The platelet release reaction: granules' constituents, secretion and functions.

Authors:  F Rendu; B Brohard-Bohn
Journal:  Platelets       Date:  2001-08       Impact factor: 3.862

2.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

3.  Inhibition of pinocytosis and induction of release of lysosomal contents by lysosomal overload of arterial smooth muscle cells in vitro.

Authors:  E M Muir; D E Bowyer
Journal:  Atherosclerosis       Date:  1984-01       Impact factor: 5.162

4.  Procathepsin D and cancer: From molecular biology to clinical applications.

Authors:  Vaclav Vetvicka; Aruna Vashishta; Sujata Saraswat-Ohri; Jana Vetvickova
Journal:  World J Clin Oncol       Date:  2010-11-10

5.  Regulation of Fab1 phosphatidylinositol 3-phosphate 5-kinase pathway by Vac7 protein and Fig4, a polyphosphoinositide phosphatase family member.

Authors:  Jonathan D Gary; Trey K Sato; Christopher J Stefan; Cecilia J Bonangelino; Lois S Weisman; Scott D Emr
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

Review 6.  Phosphatidylinositol 3,5-bisphosphate and Fab1p/PIKfyve underPPIn endo-lysosome function.

Authors:  Stephen K Dove; Kangzhen Dong; Takafumi Kobayashi; Fay K Williams; Robert H Michell
Journal:  Biochem J       Date:  2009-04-01       Impact factor: 3.857

7.  Platelet storage pool deficiency in mouse pigment mutations associated with seven distinct genetic loci.

Authors:  E K Novak; S W Hui; R T Swank
Journal:  Blood       Date:  1984-03       Impact factor: 22.113

Review 8.  Cathepsin D--many functions of one aspartic protease.

Authors:  Petr Benes; Vaclav Vetvicka; Martin Fusek
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-08       Impact factor: 6.312

Review 9.  Mutations in phosphoinositide metabolizing enzymes and human disease.

Authors:  Heather J McCrea; Pietro De Camilli
Journal:  Physiology (Bethesda)       Date:  2009-02

Review 10.  The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction.

Authors:  Frances M Platt; Barry Boland; Aarnoud C van der Spoel
Journal:  J Cell Biol       Date:  2012-11-26       Impact factor: 10.539

View more
  18 in total

1.  PIKfyve Deficiency in Myeloid Cells Impairs Lysosomal Homeostasis in Macrophages and Promotes Systemic Inflammation in Mice.

Authors:  Sang Hee Min; Aae Suzuki; Lehn Weaver; Jessica Guzman; Yutein Chung; Huiyan Jin; Francina Gonzalez; Claire Trasorras; Liang Zhao; Lynn A Spruce; Steven H Seeholzer; Edward M Behrens; Charles S Abrams
Journal:  Mol Cell Biol       Date:  2019-10-11       Impact factor: 4.272

2.  Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma.

Authors:  Sophia Gayle; Sean Landrette; Neil Beeharry; Chris Conrad; Marylens Hernandez; Paul Beckett; Shawn M Ferguson; Talya Mandelkern; Meiling Zheng; Tian Xu; Jonathan Rothberg; Henri Lichenstein
Journal:  Blood       Date:  2017-01-19       Impact factor: 22.113

3.  Unbiased Proteomics of Early Lewy Body Formation Model Implicates Active Microtubule Affinity-Regulating Kinases (MARKs) in Synucleinopathies.

Authors:  Michael X Henderson; Charlotte Hiu-Yan Chung; Dawn M Riddle; Bin Zhang; Ronald J Gathagan; Steven H Seeholzer; John Q Trojanowski; Virginia M Y Lee
Journal:  J Neurosci       Date:  2017-05-18       Impact factor: 6.167

4.  Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration.

Authors:  Zhongwei Cao; Raphael Lis; Ilias I Siempos; Shahin Rafii; Deebly Chavez; Koji Shido; Sina Y Rabbany; Bi-Sen Ding
Journal:  Nat Cell Biol       Date:  2015-01-26       Impact factor: 28.824

5.  Lysosome enlargement during inhibition of the lipid kinase PIKfyve proceeds through lysosome coalescence.

Authors:  Christopher H Choy; Golam Saffi; Matthew A Gray; Callen Wallace; Roya M Dayam; Zhen-Yi A Ou; Guy Lenk; Rosa Puertollano; Simon C Watkins; Roberto J Botelho
Journal:  J Cell Sci       Date:  2018-05-21       Impact factor: 5.285

6.  Deletion of PIKfyve alters alveolar macrophage populations and exacerbates allergic inflammation in mice.

Authors:  Takumi Kawasaki; Kosuke Ito; Haruhiko Miyata; Shizuo Akira; Taro Kawai
Journal:  EMBO J       Date:  2017-05-22       Impact factor: 11.598

Review 7.  PI5P and PI(3,5)P2: Minor, but Essential Phosphoinositides.

Authors:  Junya Hasegawa; Bethany S Strunk; Lois S Weisman
Journal:  Cell Struct Funct       Date:  2017-03-07       Impact factor: 2.212

8.  Active vacuolar H+ ATPase and functional cycle of Rab5 are required for the vacuolation defect triggered by PtdIns(3,5)P2 loss under PIKfyve or Vps34 deficiency.

Authors:  Lauren M Compton; Ognian C Ikonomov; Diego Sbrissa; Puneet Garg; Assia Shisheva
Journal:  Am J Physiol Cell Physiol       Date:  2016-06-22       Impact factor: 4.249

9.  Biallelic Mutations of VAC14 in Pediatric-Onset Neurological Disease.

Authors:  Guy M Lenk; Krystyna Szymanska; Grazyna Debska-Vielhaber; Malgorzata Rydzanicz; Anna Walczak; Monika Bekiesinska-Figatowska; Stefan Vielhaber; Kerstin Hallmann; Piotr Stawinski; Sonja Buehring; David A Hsu; Wolfram S Kunz; Miriam H Meisler; Rafal Ploski
Journal:  Am J Hum Genet       Date:  2016-06-09       Impact factor: 11.025

Review 10.  Phosphoinositides in autophagy: current roles and future insights.

Authors:  Lavinia Palamiuc; Archna Ravi; Brooke M Emerling
Journal:  FEBS J       Date:  2019-11-21       Impact factor: 5.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.